Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2020 Mar 30;19(2):349–357. doi: 10.1016/j.cgh.2020.03.047

Table 2.

Pain Patterns and Pain Medication Use in Patients with EO-ICP, LO-ICP, Light to Moderate Drinking with CP, and ACPa

Light to Moderate
Pain Characteristic EO-ICP (n=26) LO-ICP (n=26) Drinking with CP (n=154) ACP (n=133) P Value (Overall) P Value (EO-ICP vs LO-ICP)
Pain pattern, No. (%)
 None 1 (4) 8 (31) 27 (18) 19 (14) .10 .04
 Intermittent 8 (31) 10 (38) 53 (34) 34 (26)
 Constant 17 (65) 8 (31) 74 (48) 80 (60)
Pain severity, No. (%)
 None 1 (4) 8 (31) 27 (18) 19 (14) .07 .08
 Moderate 5 (19) 5 (19) 31 (20) 13 (10)
 Severe 20 (77) 13 (50) 96 (62) 101 (76)
Pain medication, No. (%)
 None 5 (19) 11 (42) 65 (42) 33 (25) .01 .27
 Nonnarcotics 0 (0) 2 (8) 13 (8) 7 (5)
 Intermittent narcotics 8 (31) 7 (27) 37 (24) 29 (22)
 Constant narcotics 13 (50) 6 (23) 39 (25) 64 (48)

Abbreviations: ACP, alcohol-related chronic pancreatitis; CP, chronic pancreatitis; EO-ICP, early-onset idiopathic chronic pancreatitis; LO-ICP, late-onset idiopathic chronic pancreatitis.

a

Data shown only from the North American Pancreatitis Studies continuation and validation (NAPS2-CV) study.